Xilio Therapeutics (XLO) Capital Expenditures (2020 - 2026)
Xilio Therapeutics' Capital Expenditures came in at $19,000 for Q2 2026, down 95.3% from $401,000 a year earlier and down 96.6% from the prior quarter.
Powered by 
Analysis
Xilio Therapeutics (XLO) Capital Expenditures (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Xilio Therapeutics reported Capital Expenditures of $670,000, up 53.0% year-over-year; for FY2025, it came in at $518,000.
- Capital Expenditures carries a five-year compound annual growth rate of -25.0% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $36,000 in FY2024 (-92.6%), $486,000 in FY2023 (-74.0%), $1.87 million in FY2022 (+69.7%) and $1.1 million in FY2021 (-49.7%).
- The Q2 2026 figure represents the lowest quarterly Capital Expenditures since Q4 2024.
- The fastest year-over-year change in Capital Expenditures over five years came in Q4 2021 (growth of 250.0%), and the weakest in Q2 2026 (a decline of 95.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.24 Bn | 1,102.83 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 616.11 Bn | 534.64 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 501.21 Bn | 474.32 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 367.51 Bn | 321.89 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 297.95 Bn | 261.94 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.35 Bn | 235.03 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 235.88 Bn | 191.28 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 190.74 Bn | 164.94 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 169.40 Bn | 116.05 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Xilio Therapeutics | 165.72 Mn | -361.95 Mn | - | 19,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19,000.00 |
| Mar 31, 2026 | 556,000.00 |
| Dec 31, 2025 | 95,000.00 |
| Jun 30, 2025 | 401,000.00 |
| Mar 31, 2025 | 22,000.00 |
| Dec 31, 2024 | 6,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2023 | 316,000.00 |
| Mar 31, 2023 | 170,000.00 |
| Dec 31, 2022 | 509,000.00 |
| Sep 30, 2022 | 333,000.00 |
| Jun 30, 2022 | 771,000.00 |
| Mar 31, 2022 | 254,000.00 |
| Dec 31, 2021 | 378,000.00 |
| Sep 30, 2021 | 114,000.00 |
| Jun 30, 2021 | 438,000.00 |
| Mar 31, 2021 | 170,000.00 |
| Dec 31, 2020 | 108,000.00 |
API Access
Xilio Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=XLO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "XLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=XLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();